628 related articles for article (PubMed ID: 24726420)
21. Exacerbations in cystic fibrosis: 3--Management.
Smyth A; Elborn JS
Thorax; 2008 Feb; 63(2):180-4. PubMed ID: 18234661
[TBL] [Abstract][Full Text] [Related]
22. Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis.
Tepper LA; Utens EM; Caudri D; Bos AC; Gonzalez-Graniel K; Duivenvoorden HJ; van der Wiel EC; Quittner AL; Tiddens HA
Eur Respir J; 2013 Aug; 42(2):371-9. PubMed ID: 23314900
[TBL] [Abstract][Full Text] [Related]
23. Is sweat chloride predictive of severity of cystic fibrosis lung disease assessed by chest computed tomography?
Caudri D; Zitter D; Bronsveld I; Tiddens H
Pediatr Pulmonol; 2017 Sep; 52(9):1135-1141. PubMed ID: 28586522
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
25. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships.
Edwards EA; Metcalfe R; Milne DG; Thompson J; Byrnes CA
Pediatr Pulmonol; 2003 Aug; 36(2):87-93. PubMed ID: 12833486
[TBL] [Abstract][Full Text] [Related]
26. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis.
Brody AS; Sucharew H; Campbell JD; Millard SP; Molina PL; Klein JS; Quan J
Am J Respir Crit Care Med; 2005 Nov; 172(9):1128-32. PubMed ID: 16100015
[TBL] [Abstract][Full Text] [Related]
27. HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis.
Edwards EA; Narang I; Li A; Hansell DM; Rosenthal M; Bush A
Eur Respir J; 2004 Oct; 24(4):538-44. PubMed ID: 15459130
[TBL] [Abstract][Full Text] [Related]
28. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis.
Aurora P; Bush A; Gustafsson P; Oliver C; Wallis C; Price J; Stroobant J; Carr S; Stocks J;
Am J Respir Crit Care Med; 2005 Feb; 171(3):249-56. PubMed ID: 15516530
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.
Farrell PM; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Lai HC; Makholm LM; Rock MJ; Splaingard ML
Pediatr Pulmonol; 2003 Sep; 36(3):230-40. PubMed ID: 12910585
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis.
Breuer O; Caudri D; Akesson L; Ranganathan S; Stick SM; Schultz A;
Eur Respir J; 2018 May; 51(5):. PubMed ID: 29678944
[TBL] [Abstract][Full Text] [Related]
31. The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease.
Nasr SZ; Sakmar E; Christodoulou E; Eckhardt BP; Streetman DS; Strouse PJ
Pediatr Pulmonol; 2010 May; 45(5):440-9. PubMed ID: 20425851
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia.
Pifferi M; Bush A; Pioggia G; Caramella D; Tartarisco G; Di Cicco M; Zangani M; Chinellato I; Maggi F; Tezza G; Macchia P; Boner A
Thorax; 2012 Nov; 67(11):993-9. PubMed ID: 22771515
[TBL] [Abstract][Full Text] [Related]
33. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease?
Loeve M; Lequin MH; de Bruijne M; Hartmann IJ; Gerbrands K; van Straten M; Hop WC; Tiddens HA
Radiology; 2009 Oct; 253(1):223-9. PubMed ID: 19710003
[TBL] [Abstract][Full Text] [Related]
35. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
36. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray.
Puderbach M; Eichinger M; Haeselbarth J; Ley S; Kopp-Schneider A; Tuengerthal S; Schmaehl A; Fink C; Plathow C; Wiebel M; Demirakca S; Müller FM; Kauczor HU
Invest Radiol; 2007 Oct; 42(10):715-25. PubMed ID: 17984769
[TBL] [Abstract][Full Text] [Related]
37. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.
Mott LS; Park J; Murray CP; Gangell CL; de Klerk NH; Robinson PJ; Robertson CF; Ranganathan SC; Sly PD; Stick SM;
Thorax; 2012 Jun; 67(6):509-16. PubMed ID: 22201161
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
39. Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis.
Kotnik Pirš A; Krivec U; Simčič S; Seme K
BMC Pulm Med; 2016 Nov; 16(1):161. PubMed ID: 27884144
[TBL] [Abstract][Full Text] [Related]
40. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation.
Shah RM; Sexauer W; Ostrum BJ; Fiel SB; Friedman AC
AJR Am J Roentgenol; 1997 Aug; 169(2):375-80. PubMed ID: 9242738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
